Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects

Metabolism: Clinical and Experimental

Volumn 48, Issue 9, 1999, Pages 1152-1156

  Lanzi, Roberto ^a,b   Luzi, Livio ^a   Caumo, Andrea ^a   Andreotti, Anna Claudia ^a   Manzoni, Marco Federico ^a   Malighetti, Maria Elena ^a   Sereni, Lucia Piceni ^a   Pontiroli, Antonio Ettore ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; FATTY ACID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL;

EID: 0032871105     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90130-0     Document Type: Article

References (12)

1. Pontiroli AE, Lanzi R. Monti LD, et al: Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects. J Endocrinol Invest 13:539-542, 1990
2. Lanzi R, Manzoni MF, Andreotti AC. et al: Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects. J Clin Endocrionol Metab 82:2239-2243, 1997
3. Opie LH, Walfish PG: Plasma free fatty acid concentration in obesity. N Engl J Med 268:757-760, 1963
4. Golay A, Swislocki AL, Chen YD. et al: Effects of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentration. J Clin Endocrinol Metab 63:481-484, 1986
5. Veldhuis JD, Iranmanesh A, Ho KKY, et al: Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59, 1991
6. Pontiroli AE, Manzoni MF, Malighetti ME, et al: Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. J Clin Endocrinol Metab 81:3998-4001, 1996
7. Luzi L, Battezzati A, Perseghin G. et al: Combined pancreas and kidney transplantation normalizes protein metabolism in IDD uremic patients. J Clin Invest 93:1948-1958, 1994
8. Andreotti AC, Lanzi R, Manzoni MF, et al: Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism 43:1207-1213, 1994
9. Schwartz MW, Figlewicz DP, Baskin DG, et al: Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 13:387-414. 1992
10. Baskin DG, Porte D Jr. Guest K, et al: Regional concentrations of insulin in the rat brain. Endocrinology 112:898-903, 1983
11. Baskin DG, Stein LJ, Ikeda H, et al: Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci 36:627-633. 1985
12. Folli F, Bonfanti L, Renard E, et al: Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 14:6412-6422, 1994